These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11332128)

  • 1. [Effect of tissue factor pathway inhibitor on the adhesion of platelet onto polyethylene and polyvinylchloride membranes].
    Leng X; Wang C; Song L; Wang P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Mar; 18(1):97-9. PubMed ID: 11332128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of tissue factor pathway inhibitor (TFPI) as topically applied antithrombotic agent.
    Aagaard S; Hjortdal VE; Barker JH
    APMIS Suppl; 2003; (109):102-7. PubMed ID: 12874959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glow discharge plasma treatment of polyethylene tubing with tetraglyme results in ultralow fibrinogen adsorption and greatly reduced platelet adhesion.
    Cao L; Sukavaneshvar S; Ratner BD; Horbett TA
    J Biomed Mater Res A; 2006 Dec; 79(4):788-803. PubMed ID: 16883583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility.
    Balakrishnan B; Kumar DS; Yoshida Y; Jayakrishnan A
    Biomaterials; 2005 Jun; 26(17):3495-502. PubMed ID: 15621239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemocompatible control of sulfobetaine-grafted polypropylene fibrous membranes in human whole blood via plasma-induced surface zwitterionization.
    Chen SH; Chang Y; Lee KR; Wei TC; Higuchi A; Ho FM; Tsou CC; Ho HT; Lai JY
    Langmuir; 2012 Dec; 28(51):17733-42. PubMed ID: 23181727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro method for assessing biomaterial-associated platelet activation.
    LaFayette NG; Skrzypchak AM; Merz S; Bartlett RH; Annich GM
    ASAIO J; 2007; 53(2):159-62. PubMed ID: 17413554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro platelet interactions with a heparin-polyvinyl alcohol hydrogel.
    Cholakis CH; Sefton MV
    J Biomed Mater Res; 1989 Apr; 23(4):399-415. PubMed ID: 2708415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen conformation and platelet reactivity in relation to material-blood interaction: effect of stress hormones.
    Barbucci R; Lamponi S; Magnani A
    Biomacromolecules; 2003; 4(6):1506-13. PubMed ID: 14606874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor, its inhibitor, and the thrombogenicity of two new synthetic membranes.
    Zemanova P; Opatrny K; Vit L; Sefrna F
    Artif Organs; 2005 Aug; 29(8):651-7. PubMed ID: 16048482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
    Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
    Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials.
    Sagnella S; Mai-Ngam K
    Colloids Surf B Biointerfaces; 2005 May; 42(2):147-55. PubMed ID: 15833667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
    Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Mollnes TE
    Ann Thorac Surg; 2004 Jul; 78(1):38-44; discussion 44-5. PubMed ID: 15223398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of platelet adhesion on polysulfone porous catheter by saline solution perfusion, II. Ex vivo and in vivo investigation.
    Khang G; Park JB; Lee HB
    Biomed Mater Eng; 1996; 6(2):123-34. PubMed ID: 8761522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma.
    Amirkhosravi A; Meyer T; Chang JY; Amaya M; Siddiqui F; Desai H; Francis JL
    Thromb Haemost; 2002 Jun; 87(6):930-6. PubMed ID: 12083498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in hemocompatibility of chitosan/soy protein composite membranes by heparinization.
    Wang X; Shi N; Chen Y; Li C; Du X; Jin W; Chen Y; Chang PR
    Biomed Mater Eng; 2012; 22(1-3):143-50. PubMed ID: 22766713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemocompatibility and anaphylatoxin formation of protein-immobilizing polyacrylonitrile hemodialysis membrane.
    Liu TY; Lin WC; Huang LY; Chen SY; Yang MC
    Biomaterials; 2005 Apr; 26(12):1437-44. PubMed ID: 15482832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen and von Willebrand's factor adsorption are both required for platelet adhesion from sheared suspensions to polyethylene preadsorbed with blood plasma.
    Kwak D; Wu Y; Horbett TA
    J Biomed Mater Res A; 2005 Jul; 74(1):69-83. PubMed ID: 15909286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.